DataCloudKnowledgetrainingcoordination

L1000 LINCS DCIC FIBR014 MCLF162SZ 6H J11 rosiglitazone 4uM.tsv.gz (File)

Taxon:

Homo sapiens

Taxon (Entity type)

Subject:

MCLF162SZ

Subject (Entity type)

Project:

LINCS-2021

Project (Entity type)

File Format:

TSV

File Format (Entity type)

Dcc Asset:

datapackage.zip

Processed File (Entity type)

Dcc:

LINCS

DCC (Entity type)

Data Type:

gene expression profile

Data Type (Entity type)

Compression Format:

GZIP format

File Format (Entity type)

Biosample:

L1000 LINCS DCIC 2021 FIBR014 MCLF162SZ 6H J11 rosiglitazone 4uM

Biosample (Entity type)

Assay Type:

landmark transcript profiling assay

Assay Type (Entity type)

Uncompressed Size In Bytes:191 KB

Size In Bytes:89.6 KB

Sha256:55bd5fb67281cdfca0204de869983a54c5ea2491000235fbcb86e45edd7579ab

Persistent Id:drs://drs.lincs-dcic.org/87b9dd4586fc8c84e86c8ad584401781

Mime Type:application/gzip

Md5:87b9dd4586fc8c84e86c8ad584401781

Filename:L1000_LINCS_DCIC_FIBR014_MCLF162SZ_6H_J11_rosiglitazone_4uM.tsv.gz

Creation Time:2021-01-21T00:00:00

Access Url:

drs://drs.lincs-dcic.org/87b9dd4586fc8c84e86c8ad584401781

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 FIBR014 MCLF162SZ 6H J11 rosiglitazone 4uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project

L1000 LINCS DCIC 2021 FIBR014 MCLF162SZ 6H J11 rosiglitazone 4uM

Biosample (Entity type)

A biosample from LINCS produced as part of the LINCS 2021 project

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.